The country's largest drugmaker, Ranbaxy Laboratories, received the US food and drug administration (FDA) nod to sell generic version of Risperdal used in the treatment of schizophrenia in the US. As per the information on the regulator's website, the company has got a go ahead from FDA to market and manufacture Risperidone in multiple strengths of 0.25 mg to 4 mg. The drug Risperidone is used to is used to treat the symptoms of schizophrenia. It is also to treat behaviour problems such as aggression and self-injury and sudden mood changes in teenagers and children with autism.
As Indians we know India in itself is an amazing nation and even the world agrees with that, however, grass is always greener on the other side and that is why Indians desire to immigrate a More
Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion More